跳转至内容
Merck
CN

09293

2-羟乙胺丙胺

≥98.0% (GC)

别名:

N-(2-羟乙基)-1,3-丙二胺

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
NH2CH2CH2CH2NHCH2CH2OH
化学文摘社编号:
分子量:
118.18
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
224-718-0
Beilstein/REAXYS Number:
1734412
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

assay

≥98.0% (GC)

refractive index

n20/D 1.486

bp

250-252 °C (lit.)

density

1.007 g/mL at 20 °C (lit.)

SMILES string

NCCCNCCO

InChI

1S/C5H14N2O/c6-2-1-3-7-4-5-8/h7-8H,1-6H2

InChI key

GHKSKVKCKMGRDU-UHFFFAOYSA-N

Gene Information

rat ... Grin2a(24409)

Other Notes

哺乳动物糖原脱支酶抑制剂;照相显影加速剂


pictograms

CorrosionExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B - Skin Sens. 1

存储类别

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

296.6 °F

flash_point_c

147 °C

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme.
B K Gillard et al.
Biochemistry, 16(18), 3978-3987 (1977-09-06)
Stephany Y Tzeng et al.
International journal of nanomedicine, 6, 3309-3322 (2012-01-10)
Biodegradable poly(ester amine) (PEA)-based and poly(amido amine) (PAA)-based nanoparticles were developed for efficient in vitro siRNA delivery to human umbilical vein endothelial cells (HUVECs). They were screened, characterized, and compared with traditionally studied DNA-containing particles. Several of the polymeric nanoparticles
Panagiotis Mastorakos et al.
Journal of controlled release : official journal of the Controlled Release Society, 262, 37-46 (2017-07-12)
The discovery of powerful genetic targets has spurred clinical development of gene therapy approaches to treat patients with malignant brain tumors. However, lack of success in the clinic has been attributed to the inability of conventional gene vectors to achieve